Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Pnu-100480
2. U-480 Compound
1. 168828-58-8
2. Oxazolidininone
3. Pnu-100480
4. U-100480
5. (s)-n-((3-(3-fluoro-4-thiomorpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide
6. U 100480
7. Pnu 100480
8. Pf-02341272
9. Nsc-742407
10. Mmv688756
11. Nsc742407
12. 3a71182l8p
13. Acetamide, N-[[(5s)-3-[3-fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-
14. Sutezolid [inn]
15. N-((3-(3-fluoro-4-(1,4-thiazaperhydroin-4-yl)phenyl)-2-oxo-1,3-oxazolidin-5-yl)methyl)acetamide
16. Sutezolid [usan]
17. Sutezolid [usan:inn]
18. Unii-3a71182l8p
19. N-[[(5s)-3-(3-fluoro-4-thiomorpholino-phenyl)-2-oxo-oxazolidin-5-yl]methyl]acetamide
20. 9en
21. N-{[3-(3-fluoro-4-(1,4-thiazaperhydroin-4-yl)phenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide
22. Sutezolid (usan/inn)
23. Pf-2341272
24. Sutezolid [who-dd]
25. N-[[(5s)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
26. Chembl288149
27. Schembl2152517
28. Sutezolid (pnu-100480)
29. Sutezolid, >=98% (hplc)
30. Dtxsid20168611
31. Pnu-480
32. Zinc3810825
33. Bdbm50560041
34. Mfcd00937821
35. Cs-5568
36. Db11905
37. Nsc 742407
38. Ncgc00348189-01
39. Ncgc00348189-02
40. As-74370
41. Hy-10392
42. Pf 02341272
43. D10167
44. W13554
45. Sr-05000022502
46. Sr-05000022502-1
47. Q15427841
48. (s)-n-[[3-[3-fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl] Methyl]acetamide
49. (s)-n-[[3-[3-fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide
50. Acetamide, N-(((5s)-3-(3-fluoro-4-(4-thiomorpholinyl)phenyl)-2-oxo-5-oxazolidinyl) Methyl)-
51. Acetamide, N-((3-(3-fluoro-4-(4-thiomorpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-, (s)-
52. Acetamide, N-[[(5s)-3-[3-fluoro-4-(thiomorpholinyl)-phenyl]-2-oxo--5-oxazolidinyl]methyl]-
53. N-(((5s)-3-(3-fluoro-4-(thiomorpholin-4-yl)phenyl)-2-oxooxazolidin-5-yl)methyl) Acetamide
54. N-{[(5s)-3-[3-fluoro-4-(thiomorpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide
| Molecular Weight | 353.4 g/mol |
|---|---|
| Molecular Formula | C16H20FN3O3S |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 353.12094084 g/mol |
| Monoisotopic Mass | 353.12094084 g/mol |
| Topological Polar Surface Area | 87.2 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 476 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
100
PharmaCompass offers a list of Sutezolid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sutezolid manufacturer or Sutezolid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sutezolid manufacturer or Sutezolid supplier.
PharmaCompass also assists you with knowing the Sutezolid API Price utilized in the formulation of products. Sutezolid API Price is not always fixed or binding as the Sutezolid Price is obtained through a variety of data sources. The Sutezolid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sutezolid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sutezolid, including repackagers and relabelers. The FDA regulates Sutezolid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sutezolid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sutezolid supplier is an individual or a company that provides Sutezolid active pharmaceutical ingredient (API) or Sutezolid finished formulations upon request. The Sutezolid suppliers may include Sutezolid API manufacturers, exporters, distributors and traders.
Sutezolid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sutezolid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sutezolid GMP manufacturer or Sutezolid GMP API supplier for your needs.
A Sutezolid CoA (Certificate of Analysis) is a formal document that attests to Sutezolid's compliance with Sutezolid specifications and serves as a tool for batch-level quality control.
Sutezolid CoA mostly includes findings from lab analyses of a specific batch. For each Sutezolid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sutezolid may be tested according to a variety of international standards, such as European Pharmacopoeia (Sutezolid EP), Sutezolid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sutezolid USP).
